After this article was published, similarities were noted between this article [1] and submissions by other research groups which call into question the validity and provenance of the reported results. In light of these issues, the PLOS ONE Editors issue this Expression of Concern.
PLOS attempted to discuss the concerns with the authors, but the authors either did not respond or could not be reached through the email addresses on file with the journal.
Reference
Citation: The PLOS ONE Editors (2023) Expression of Concern: Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome. PLoS ONE 18(5): e0285545. https://doi.org/10.1371/journal.pone.0285545
Published: May 4, 2023
Copyright: © 2023 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.